Integer (NYSE:ITGR) Announces Earnings Results

Integer (NYSE:ITGR) posted its quarterly earnings data on Monday. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22, FiscalAI reports. The company had revenue of $464.11 million during the quarter, compared to analyst estimates of $450.67 million. Integer had a net margin of 7.64% and a return on equity of 12.83%.

Integer Price Performance

NYSE ITGR opened at $121.07 on Monday. The company has a 50 day simple moving average of $93.88 and a 200-day simple moving average of $88.98. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of 30.19, a price-to-earnings-growth ratio of 2.89 and a beta of 0.61. Integer has a 52-week low of $62.00 and a 52-week high of $123.50.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research reports. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Piper Sandler restated an “overweight” rating and set a $97.00 target price (up from $87.00) on shares of Integer in a report on Friday, May 1st. Citigroup lifted their price target on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. HC Wainwright reaffirmed a “buy” rating on shares of Integer in a report on Friday, July 24th. Finally, KeyCorp reiterated an “overweight” rating and set a $104.00 price objective on shares of Integer in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $97.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC lifted its position in Integer by 0.6% in the 4th quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after buying an additional 136 shares in the last quarter. Orion Porfolio Solutions LLC grew its holdings in shares of Integer by 1.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock valued at $1,200,000 after acquiring an additional 138 shares in the last quarter. Lido Advisors LLC increased its stake in shares of Integer by 5.5% in the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares during the last quarter. Osaic Holdings Inc. increased its stake in shares of Integer by 8.0% in the second quarter. Osaic Holdings Inc. now owns 2,543 shares of the medical equipment provider’s stock worth $312,000 after acquiring an additional 188 shares during the last quarter. Finally, MML Investors Services LLC raised its holdings in shares of Integer by 2.4% during the second quarter. MML Investors Services LLC now owns 8,222 shares of the medical equipment provider’s stock worth $1,011,000 after acquiring an additional 196 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.